Get Instant Summarized Text (Gist) A clinical trial demonstrated that cord blood-derived natural killer (NK) cells pre-complexed with the bispecific antibody AFM13 showed high efficacy in treating ...

NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma Phase I trial demonstrates AFM13-NK cells are safe and highly effective in heavily pretreated ...

Adaptive NK cells, aNK cells, are a subset of NK cells that can remember past infections or tumors and react more strongly the next time they encounter the same threat. This ability makes them ...

Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours Oslo, Norway, 22 April 2025 – ...

Olimpija na drugi finalni tekmi državnega prvenstva v dvorani Tivoli gosti SIJ Acroni Jesenice. Prenos je na TV SLO 2 in na MMC-ju. Če zmagajo Ljubljančani, bodo že osvojili jubilejni 20. naslov.

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma refocuses its relationship with Innate Pharma from oncology to ...

Inspired by the viral TikTok trend of the 'everything shower', Space NK's latest collection includes all the bath products you need for a soothing, self-care evening at home. Featuring £165 worth ...

This grant application represents a significant milestone in our commitment to understanding NK-1 receptor biology and its role in neurological diseases, specifically Alzheimer's. We believe that ...

Gilead Sciences has made another foray into the natural killer (NK) cell category, paying $300 million upfront to access Dragonfly Therapeutics' TriNKET platform to find therapies for cancer and ...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...